Indivior Pharmaceuticals, Inc. Net Fee Amt
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-28
- 2026-08-27: Net Fee Amt $416.92K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-27 | $416.92K S-4 · filed 2026-08-28 |
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-28
| Period end | Net Fee Amt |
|---|---|
| 2026-08-27 | $416.92K S-4 · filed 2026-08-28 |